Inventor · Wiesbaden, DE

Frauke Pohlki

29Patents
3h-index
38Co-inventors
55Inventor score

Filing activity: Apr 22, 2010 → Oct 25, 2017

Most-cited inventions

PatentTitleAreaCited byStatus
US8076326B2 N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor Chemistry; Metallurgy 17 Active
US8183237B2 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor Chemistry; Metallurgy 3 Active
US9828381B2 Substituted pyrazolopyrimidines and method of use Chemistry; Metallurgy 3 Active
US8710059B2 N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor Chemistry; Metallurgy 3 Active
US8343959B2 N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor Chemistry; Metallurgy 3 Active
US8362010B2 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor Chemistry; Metallurgy 2 Active
US8772313B2 Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor Chemistry; Metallurgy 2 Active
US8883839B2 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 1 Active
US8853196B2 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 1 Active
US9656955B2 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 1 Active
US8518933B2 Modulators of 5-HT receptors and methods of use thereof Emerging Cross-Sectional Technologies 1 Active
US9051280B2 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 1 Active
US8546377B2 Modulators of 5-HT receptors and methods of use thereof Chemistry; Metallurgy 1 Active
US8846741B2 N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 1 Active
US8846743B2 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 1 Active
US10155770B2 Substituted pyrazolopyrimidines and method of use Chemistry; Metallurgy 0 Active
US9365512B2 Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 0 Active
US9227930B2 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 0 Active
US10160744B2 Quinoline compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor Chemistry; Metallurgy 0 Active
US9045459B2 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 0 Active
US9586942B2 Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 0 Active
US9701679B2 Modulators of 5-HT receptors and methods of use thereof Emerging Cross-Sectional Technologies 0 Active
US8877794B2 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 0 Active
US8846663B2 Modulators of 5-HT receptors and methods of use thereof Emerging Cross-Sectional Technologies 0 Active
US9309200B2 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.